Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring chiral building blocks. Its structure supports the formation of complex molecules in medicinal chemistry, especially in drugs targeting central nervous system disorders and metabolic diseases. Commonly employed in the preparation of prodrugs and ester derivatives to enhance bioavailability. Also utilized in research settings for the design of novel compounds with improved pharmacokinetic profiles.